GC4419 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

How Datavault AI Inc. is turning U.S. critical minerals into digital assets through American Strategic Minerals Inc. deal (NASDAQ: DVLT)

Representative image of a space surveillance network concept as Germany and Australia deepen defence cooperation on early warning systems aimed at tracking emerging satellite threats from Russia and China.

Germany and Australia sign space surveillance agreement targeting Russia and China satellite threats

Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss

Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity

Read More

1 minute read

Pharma Industry News

Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419

Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer…

bypharmanewsdaily

July 14, 2020

web analytics